Valuation dashboard for Agilent Technologies, Inc. (A) with P/E 29.51, P/B 5.75, EV/EBITDA 22.65 and dividend yield 0.67%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS).
Analysis Summary
Agilent Technologies, Inc. reported revenue of $6.95B in the most recent fiscal year, growing at a 5-year CAGR of 5.4%. Net income reached $1.30B, with a 12.6% 5-year CAGR.
Trailing-twelve-month margins: gross margin 53.7%, operating margin 22.2%, net margin 19.5%.
At the current price of $153.69, A trades at a P/E of 29.51 and an ROE of 20.47%. Market capitalisation stands at $43.4B, placing it among large-cap names.
Valuation Ratios
| P/E Ratio | 29.51 |
| Price / Book | 5.75 |
| EV / EBITDA | 22.65 |
| Dividend Yield | 0.67% |
Valuation Models
| DCF Fair Value | $68.19 |
| vs Current Price | -55.6% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| A | Agilent Technologies, Inc. | $43.4B | 29.51 | 5.75 | 20.5% |
| INSM | Insmed Incorporated | $26.6B | 32.75 | -111.3% | |
| BDX | Becton, Dickinson and Company | $49.0B | 54.89 | 2.05 | 3.8% |
| CAH | Cardinal Health, Inc. | $54.5B | 30.94 | -59.7% | |
| EW | Edwards Lifesciences Corporation | $49.6B | 49.28 | 4.65 | 9.7% |
| HLN | Haleon plc | $40.5B | 18.64 | 1.84 | 9.9% |
| ALC | Alcon Inc. | $32.2B | 51.85 | 1.52 | |
| IQV | IQVIA Holdings Inc. | $44.2B | 34.40 | 7.58 | 20.9% |
Price
| Price | $153.69 |
| Market Cap | $43.4B |
| Exchange | NYSE |
| Country | US |
Profitability
| Return on Equity | 20.47% |
| Return on Invested Capital | 11.88% |
| Return on Assets | 10.31% |
| Gross Margin | 53.73% |
| Operating Margin | 22.23% |
| Net Margin | 19.53% |
Related companies: ALC · BDX · CAH · EW · HLN · INSM · IQV
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of A: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks